CDC: Bad flu season has peaked in the United States
One of the worst flu seasons in years has reached its peak and is improving, officials with the Centers for Disease Control ...
FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
USA TODAY on MSN10d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.
The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
Exclusive: FDA staffers told that 'woman,' 'disabled' among banned words; White House says it’s an error
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according ...
The Financial Express1d
Glenmark recalls 15 lakh bottles of ADHD medication due to ‘CGMP Deviations’ in United States
ADHD is a neurodevelopmental disorder that affects a person's ability to focus, control impulses, and regulate their activity ...
JD Supra7d
FDA Continues Push to Improve Food Labeling Practices in the United States
In September 2022, former President Biden convened the White House Conference on Hunger, Nutrition, and Health, during which ...
Meeting of US FDA vaccine advisers canceled, committee member says
It's the second such disruption to a federal vaccine advisory panel since Robert F. Kennedy Jr. became the nation’s top ...
Morningstar7d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...
manilatimes7d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
DM is an immune-mediated myopathy characterized by chronic inflammation of the skin and muscles, progressive muscle weakness, and potential involvement of internal organs. The role of complement ...